March 2021 - Page 11 of 13 - NetworkNewsWire

TuesdayMar 09, 2021 9:00 am

Creating Shareholder Value with a Machine-as-a-Service (MaaS) Business Model

NetworkNewsWire Editorial Coverage: The internet boom in the 1990s, with the genesis of application service providers ("ASP"), set the stage for the Software-as-a-Service ("SaaS") model that now has found its way into nearly every industry. In a SaaS model, providers offer their technology over a set period of time, effectively locking in recurring revenue and a higher profit rather than selling the product outright. Since then, the “as-a-Service” model has been expanded into new verticals in a global economy now eager to accept the process. Because of large margins, Wall Street typically places high valuations on companies that employ the…

MondayMar 08, 2021 1:01 pm

ROTH Announces Health & Wellness Track for Virtual 33rd Annual Roth Conference

ROTH is hosting its 33rd Annual Roth Conference virtually this year, from March 15-17. A key part of the conference is scheduling 1-on-1/small group meetings for institutional investors to meet with leading Health and Wellness companies, including U.S. cannabis operators, global operators, ancillary providers, and hemp CBD companies. In addition, ROTH is hosting virtual fireside chats and three industry panels discussing the burgeoning industries of cannabis and psychedelics. COMPANIES AVAILABLE FOR 1X1 MEETINGS: Canadian and Global LPs: IM Cannabis (CSE: IMCC), MediPharm Labs (TSX: LABS) Hemp CBD: cbdMD (NYSE American: YCBD) S. Cannabis Ancillary Providers: Agrify (NASDAQ: AGFY), Innovative Industrial…

MondayMar 08, 2021 12:06 pm

Relax, Robots Have it Handled

Massive opportunity ahead says CEO of Autonomous Security Robot maker Knightscope Wide ranging interview discloses vast potential in federal applications Knightscope’s state of the art ASRs provide cost effective 24/7/365 security The rise of machines has arrived. Relax, it isn’t the rise of Skynet, the malevolent neural network superintelligence system from the movie Terminator. This rise of machines has no malice. In fact, these machines benefit society by uniquely combining robotics, self-driving technology, and artificial intelligence to reduce crime as well as provide safety, security, and real-time data in a multitude of settings. With the rise of its Autonomous Security…

MondayMar 08, 2021 11:56 am

Ideanomics Inc. (NASDAQ: IDEX) Acquires 20% Stake in Italian Listed Electric Motorcycle Maker Energica

Ideanomics, Inc. (NASDAQ: IDEX) recently entered into an investment agreement promising to purchase over 6 million Energica ordinary shares using a subscribed-shares arrangement that priced each subscribed share at Euro 1.78 In total, IDEX would invest approximately 13 million dollars in the Italy-based manufacturer of all-electric high-performance motorcycles According to IDEX CEO Alf Poor, the investment was driven by Energica’s manufacture of high-performance products that produce zero emissions In 2020, Energica experienced a 187% increase in revenue compared to 2019, and there is high demand for Energica’s motorcycles in the U.S. Ideanomics (NASDAQ: IDEX), a global company focused on investing…

MondayMar 08, 2021 11:10 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) and Canada House Wellness Group (CSE: CHV) Partner, Bringing New Cannabis 2.0 to More Canadians

Canada House subsidiary Abba Medix to distribute Pure Extract line of full spectrum oil vape and edible products throughout its nationwide network Partnership widens Pure Extracts’ footprint in Canada’s growing Cannabis 2.0 market Global extraction product market expected to reach $28.5 billion in next six years New agreement strengthens Pure Extracts’ sales channels as it looks towards international expansion There’s plenty of media coverage about increasing legalization of cannabis for medical and adult recreational use driving a broad market expected to reach $73.6 billion by 2027 (https://nnw.fm/9uqbv), but not as much about the cannabis extraction market that is growing at nearly…

MondayMar 08, 2021 10:51 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Takes Bladder Cancer Battle to Next Level

Imagin Medical has developed a technology, currently entering the manufacturing stage, which it believes will revolutionize bladder cancer surgical imaging The company’s technology, the i/Blue Imaging System, can display blue and white light images of the bladder side-by-side simultaneously, allowing surgeons greater ability to detect and remove tumors Imagin has raised a $2.165 million convertible note offering to fund the company during the manufacturing phase of its surgical imaging system as well as the U.S. Food and Drug Administration (“FDA”) approval process Bladder cancer is one of the most prevalent cancers in the United States, particularly in men, and is…

FridayMar 05, 2021 12:36 pm

Brain Scientific Inc. (BRSF) Making EEGs Accessible in Emergency Departments

Head CTs, MRIs are most-used but not most-effective tool for head trauma or neurological issues in triage EEG changed clinical management of 76.2% of patients, even when CT or MRI was available Brain Scientific has overcome key barriers causing EEG underuse in emergency medicine Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company, is making EEGs accessible in emergency departments (“ED”) with cutting-edge tech that bridges the widening gap in access to quality care. As the public becomes more aware of head trauma's long-term effects, triages fill up with potential TBIs and acute neurological conditions. Facilities are scrambling to adapt to…

FridayMar 05, 2021 12:21 pm

Predictive Oncology Inc. (NASDAQ: POAI) Announces Fundraising Agreements to Raise Estimated $25M

POAI completes two separate fundraising initiatives: private placement, direct offering. Two fundraising campaigns expected to result in $17.6 million, $7.4 million respectively. Predictive Oncology plans to use funds to pay off debt as well as for working capital, general corporate purposes. Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has announced two funding initiatives that together total an estimated $25 million. The company has entered into securities purchase agreements with institutional and accredited investors (https://nnw.fm/XnYe8) to raise approximately $17.6 million and is involved in a direct offering that is…

FridayMar 05, 2021 12:06 pm

Uranium Energy Corp. (NYSE American: UEC) Positioned Favorably to Capitalize on Rising Uranium Demand

Increased nuclear power projects fueling rising demand for uranium UEC controls one of the largest historical uranium exploration and development databases in United States UEC property portfolio includes properties previously explored and developed by senior energy firms UEC has fully licensed, low cost, ISR projects positioned to supply the U.S. Uranium Reserve Nuclear energy included in Democratic Party’s energy platform for first time in 48 years After spending a solid ten years in a downward trend, uranium stocks are now making fresh 52-week highs amid increased demand for energy (https://nnw.fm/3yBqG). Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration…

FridayMar 05, 2021 11:14 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) and WPD Pharmaceuticals (CSE: WBIO) (Frankfurt: 8SV1) Get the Green Light for Clinical Trials’ Protocols from Ethics Panels

CNS Pharmaceuticals holds the exclusive worldwide license to the Berubicin chemical compound Berubicin is CNSP’s lead, novel anthracycline candidate for the treatment of glioblastoma multiforme (“GBM”) that was the subject of a previously conducted Phase 1 clinical trial, which had a clinical benefit response rate of 44% CNSP has sublicensed Berubicin to WPD Pharmaceuticals in 31 countries primarily in eastern Europe and western Asia WPD plans to conduct a Phase 2 trial in adults with GBM and a Phase 1 trial for pediatric patients with malignant gliomas CNSP intends to conduct its own Phase 2, potentially pivotal, trial in s…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

Month: March 2021